Henrietta J. Ditzen
Associate
Düsseldorf
henrietta.ditzen@lw.com
+49.211.8828.4629
PRACTICES
- European Union Life Sciences Regulatory
- Mergers & Acquisitions
INDUSTRIES
- Healthcare & Life Sciences
EDUCATION
- LL.M., Columbia University, 2013
- Second German State Exam, Higher Regional Court, Hamburg, 2011
- First German State Exam, Rheinische Friedrich-Wilhelms-Universität, Bonn, 2009
LANGUAGES SPOKEN
- German
- English
PROFILE
Henrietta J. Ditzen is an associate in the Düsseldorf office of Latham & Watkins and a member of the firm’s Corporate Department. Henrietta focuses on transactions as well as corporate and regulatory matters in the healthcare and life sciences industries.
She has extensive experience advising financial investors in the healthcare market on:
- M&A transactions
- Restructurings
In the life sciences sector, Henrietta advises German and international pharmaceutical companies and medical device manufacturers with regard to:
- M&A transactions
- German and EU regulatory matters
EXPERIENCE
Henrietta’s experience includes advising:
- Acrotec (a portfolio company of The Carlyle Group) on the:
- Acquisition of Friedrich Daniels
- Acquisition of Mebus MIM-Technik
- Aliaxis on the sale of a ceramics business
- Antin Infrastructure Partners on the acquisition of the majority stake in amedes Holding AG, a provider of medical diagnostic services
- Bregal Unternehmerkapital on the acquisition of medavis GmbH
- Cheplapharm on the:
- Acquisition of the worldwide commercial rights (excluding South Korea) for Gemzar® from Eli Lilly and Company
- Acquisition of the worldwide commercial rights (excluding South Korea) for Zyprexa® from Eli Lilly and Company
- Acquisition of the medicinal products Seroquel and Seroquel XR in Europe, Russia, the US, and Canada from AstraZeneca
- Corpus Sireo in the sale of its real estate portfolio to Deutsche Bank subsidiary Deutsche Asset & Wealth Management, and the sale of the group of companies to Swiss Life
- DPE Deutsche Private Equity and Maxburg Capital Partners on the sale of PharmaZell GmbH
- EQT Partners AB on the acquisition of Siemens Audiology Solutions from Siemens
- Fresenius on the sale of the majority of Vamed’s rehabilitation business to PAI Partners
- Inari Medical on the acquisition of LimFlow
- ITM on the acquisition of a worldwide exclusive license for cancer treatment
- Juno Therapeutics on the acquisition of Stage Cell Therapeutics GmbH
- Medigo GmbH on corporate and regulatory advice in connection with establishing an online platform for medical tourism
- Novo Nordisk on the acquisition of Cardior Pharmaceuticals
- Raptor Pharmaceuticals in connection with the product commercialization of an orphan drug in the EEA
- Siemens in connection with the pending internal reorganization of its healthcare division
- Stirling Square Capital Partners on the sale of Cartonplast Group to DBAG
- Tecan Trading AG on the acquisition of IBL International Holding B.V., a developer and distributor of in-vitro diagnostic test systems
- Thoratec Corporation on clinical trials in Germany and Austria
- Trilantic on the acquisition of the Deutsche Pflege und Wohnen Group and the Argentum Group in a combined purchase procedure
- TriVascular on medical device legislation and compliance